Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Clinical utility of a 3D convolutional neural network kidney segmentation method for radionuclide dosimetry

Nathan Lamba, Hanlin Wan, Alexandria Kruzer, Ethan Platt and Aaron Nelson
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 267;
Nathan Lamba
2MIM Software Inc. Beachwood OH United States
3MIM Software Inc. Beachwood OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanlin Wan
2MIM Software Inc. Beachwood OH United States
3MIM Software Inc. Beachwood OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandria Kruzer
1MIM SOFTWARE Cleveland OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ethan Platt
2MIM Software Inc. Beachwood OH United States
3MIM Software Inc. Beachwood OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Nelson
2MIM Software Inc. Beachwood OH United States
3MIM Software Inc. Beachwood OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

267

Objectives: With the recent approvals of new molecular radiotherapy agents, new methods for measurement and assessment of absorbed dose in both normal regions and tumors will be important. Several of these new therapies will require an assessment of dose delivered to the kidneys. In order to do this, the kidneys will have to be accurately delineated, but manual segmentation can be time consuming and burdensome. Automatic methods such as atlas-based segmentation have been developed, but due to variability in patient size, patient shape, and kidney location, it can be challenging to achieve success with these methods. AI-based methods have been shown to produce excellent results when applied to segmentation problems. In this experiment our objective was to show that an AI-based method for segmenting the kidneys would produce clinically acceptable results that could be used for absorbed dose calculations or other applications related to radionuclide therapies.

Methods: Kidney ground truth volumes of interest were contoured manually on 65 anonymized images from various institutions by 6 observers. These images and segmentations were then used to train an in-house neural network. The neural network was based on the well-known U-Net architecture with 3D convolution blocks to better leverage contextual information from all directions. The network takes volumetric data as the input and outputs a probability map for each kidney, which is then binarized. A 5-fold cross validation was performed on the 65 data sets. Dice similarity coefficient (DSC), mean distance to agreement (MDA), and maximum Hausdorff distance (HD) were calculated on the 13-patient test set for each fold.

Results: The segmentation method demonstrated good accuracy with a DSC mean, median, and standard deviation of 0.93, 0.94, and 0.04 respectively. The mean, median, and standard deviation of the MDA was 0.97, 0.81, and 0.50 respectively. The mean, median, and standard deviation of the HD was 10.82, 8.42, and 6.72 respectively.

Conclusions: We found that a 3D convolutional neural network can accurately generate kidney ROIs on CT images. These regions can then be used in radionuclide dosimetry and other applications. This method can be run automatically in the background or during off hours, and therefore has the potential to save time as well as reduce inter-user variability with segmentation tasks. We would like to expand our investigation into these specific areas in the future. We would also like to investigate the utility of this method when applied to other anatomical regions.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical utility of a 3D convolutional neural network kidney segmentation method for radionuclide dosimetry
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Clinical utility of a 3D convolutional neural network kidney segmentation method for radionuclide dosimetry
Nathan Lamba, Hanlin Wan, Alexandria Kruzer, Ethan Platt, Aaron Nelson
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 267;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical utility of a 3D convolutional neural network kidney segmentation method for radionuclide dosimetry
Nathan Lamba, Hanlin Wan, Alexandria Kruzer, Ethan Platt, Aaron Nelson
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 267;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After 177Lu-Peptide Receptor Radionuclide Therapy
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • ‘In-loop’ [11C]CO2fixation: Application to the synthesis of a 11C-labeled cholesterol 24-hydroxylase inhibitor
  • Grade and IDH genotype prediction in glioma by a hybrid PET/MR with FET-PET and DSC-PWI
  • Evaluation of Methods to Decrease Formation of a Higher Molecular Weight Species When211At-Labeling of Antibody-B10 Conjugates Using Chloramine-T as Oxidant
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Dosimetry

  • Feasibility of total body dosimetry of Lu-177 SPECT-CT images recorded by a CZT camera
  • Preclinical Biodistribution and Human Radiation Dosimetry Estimates of [18F]FNP-59: a Radiotracer for Imaging Cholesterol Trafficking
  • Comparative evaluation of the new MIRDcalc dosimetry software across a compendium of radiopharmaceuticals
Show more Dosimetry

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire